JP2005538103A - アムロジピンの有機酸塩 - Google Patents

アムロジピンの有機酸塩 Download PDF

Info

Publication number
JP2005538103A
JP2005538103A JP2004524369A JP2004524369A JP2005538103A JP 2005538103 A JP2005538103 A JP 2005538103A JP 2004524369 A JP2004524369 A JP 2004524369A JP 2004524369 A JP2004524369 A JP 2004524369A JP 2005538103 A JP2005538103 A JP 2005538103A
Authority
JP
Japan
Prior art keywords
amlodipine
camphorsulfonate
camphor
acid
camphor sulfonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004524369A
Other languages
English (en)
Japanese (ja)
Inventor
ホワン チョ，ソン
ヨン，ヨン−シク
ジュン，ユン−テク
パーク，チューン−シル
リー，ヒュク−クー
リー，クワン−ヒェ
ジョン，ウン−ジュ
キム，ヨン−フーン
チョン，ジュン−ヒー
ジン，ヘ−タク
リー，スン−ハク
ジュン，スン−ハク
リム，ドン−クウォン
ヨン，キュ−ジョン
キム，ユン−チュル
パーク，キュン−ミ
カン，ヒュン−スク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ CheilJedang Corp
Original Assignee
CJ CheilJedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ CheilJedang Corp filed Critical CJ CheilJedang Corp
Publication of JP2005538103A publication Critical patent/JP2005538103A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
JP2004524369A 2002-07-30 2003-07-30 アムロジピンの有機酸塩 Pending JP2005538103A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020020044856A KR20040011751A (ko) 2002-07-30 2002-07-30 암로디핀의 유기산염
PCT/KR2003/001522 WO2004011432A1 (en) 2002-07-30 2003-07-30 Organic acid salt of amlodipine

Publications (1)

Publication Number Publication Date
JP2005538103A true JP2005538103A (ja) 2005-12-15

Family

ID=31185754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004524369A Pending JP2005538103A (ja) 2002-07-30 2003-07-30 アムロジピンの有機酸塩

Country Status (8)

Country Link
EP (1) EP1549616A4 (ko)
JP (1) JP2005538103A (ko)
KR (1) KR20040011751A (ko)
CN (1) CN1678583A (ko)
AU (1) AU2003247208A1 (ko)
BR (1) BR0313076A (ko)
MX (1) MXPA05001241A (ko)
WO (1) WO2004011432A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100913791B1 (ko) * 2006-07-21 2009-08-26 한미약품 주식회사 (ｓ)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물
KR100821688B1 (ko) 2006-08-10 2008-04-11 (주)유케이케미팜 암로디핀 라셈화물의 입체이성질체의 분리방법과 그의친수성 약물 및 그의 제조방법
PL2534153T3 (pl) 2010-02-12 2017-08-31 Pfizer Inc. Sole i polimorfy 8-fluoro-2-{4-[(metyloamino}metylo]fenylo}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-onu
CN101972254B (zh) * 2010-09-28 2012-05-30 石药集团欧意药业有限公司 一种左旋氨氯地平或其可药用盐固体制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
KR100452491B1 (ko) * 2001-03-29 2004-10-12 한미약품 주식회사 신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법

Also Published As

Publication number Publication date
MXPA05001241A (es) 2005-06-08
KR20040011751A (ko) 2004-02-11
EP1549616A4 (en) 2006-10-18
WO2004011432A1 (en) 2004-02-05
EP1549616A1 (en) 2005-07-06
CN1678583A (zh) 2005-10-05
BR0313076A (pt) 2005-06-28
AU2003247208A1 (en) 2004-02-16

Similar Documents

Publication Publication Date Title
JPH037668B2 (ko)
HU227919B1 (en) Novel amlodipine camsylate and method for preparing thereof
AU2002243069A1 (en) Novel amlodipine camsylate and method for preparing thereof
JP2008526835A (ja) シブトラミンのスルホン酸塩
JP4319491B2 (ja) アムロジピンの有機酸塩
JP4365648B2 (ja) 結晶形のアムロジピン有機酸塩
JP2006500334A (ja) アムロジピンの有機酸塩
JP2005538103A (ja) アムロジピンの有機酸塩
KR100462304B1 (ko) 암로디핀의 유기산염
KR100879972B1 (ko) 결정형의 암로디핀 유기산염
KR100496436B1 (ko) 암로디핀의 유기산염
KR20060088444A (ko) 암로디핀의 유기산염

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070619

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070918

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070926

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071219

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080305

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080610

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081216